Lymphatic filariasis (LF) is the second most common parasitic disease worldwide, after malaria. It should always be considered in the differential diagnosis for military personnel returning from disease-endemic areas. Numerous outbreaks of LF have been reported in military deployments from World War II. In contrast to the presentation of LF in indigenous populations, which often involves such uncommon complications as elephantiasis and hydrocele, the clinical presentation of LF in military personnel can vary widely and is often vague and nondescript. Common symptoms are pain and swelling of the genitalia, closely followed by lymphangitis of the arms and legs. All three species produce similar disease.
Introduction
Lymphatic filariasis (LF) is the second most common vectorborne disease, after malaria. LF is caused by three species of nematode parasites, which can be spread by a wide range of mosquito species. The World Health Organization estimated the global burden of infection to be 120 million cases, with 1 billion people being at risk of infection.1 LF is also the second most common cause of long-term disability.1 It has a widespread geographic distribution, mainly in the tropical regions of the world (Fig. 1). Wuchereria bancrqfti is the most common species and accounts for -90% of cases. Brugia malayi is confined to East and Southeast Asia, and Brugia timori is found only in Timor and nearby islands. Given its widespread distribution and the increase in military deployments in filariasis-endemic areas, it should be expected that expatriate cases would occur and that steps should be taken to prevent transmission of LF among military personnel. After a brief review of the life cycle of LF, this article examines published accounts of LF affecting more recent military deployments since World War II.
Life Cycle of LF
The life cycle of LF is given in Figure 2. The adult worms live in the lymphatic vessels, where the females produce specialized motile embryos (microfilariae) that circulate in the peripheral blood. In most parts of the world, the concentration of microfilariae peaks at night (nocturnal periodicity), coinciding with the peak biting time of the vector mosquito. In the central Pacific region, where the vector is a daytime biter, the microfilariae peak occurs at midday (diurnal periodicity). It should be noted that, after the ingestion of microfilariae, there is maturation in the mosquito but, unlike in malaria, there is no multiplication. Also unlike in malaria, the infective stage (in LF, the larvae 3 or "L3" stage) is not inoculated directly into the new host. The L3 larvae are deposited onto the skin surface and migrate down through the puncture made by the proboscis of the mosquito.2 Because of the lack of multiplication in the mosquito and the method of entry of the infective stage, it has been suggested that the transmission of filarial parasites is not as efficient as that of malaria and that many bites and/or a long period of exposure is required before infection occurs. This assumption is difficult to prove and, as shown below, may be erroneous.
Incidence of LF in Military Deployments
Many thousands of cases of filariasis occurred among the U.S. forces stationed in filariasis-endemic areas during World War II, especially in the Pacific theater, and filariasis was the leading cause of nontrauma medical evacuation in the South Pacific.3 The situation is well attested to in the literature, with -60 articles published during or soon after World War II.4 It is estimated that -38,300 naval personnel alone were exposed to filariasis and, of those, 10,421 were diagnosed as having the disease.
In one unit stationed in a highly disease-endemic area in Samoa, 70% of the exposed troops became infected.5 One-fifth of the troops stationed on a particular island were admitted to the hospital with symptoms of filariasis, and there were 127 cases of filariasis at a field hospital in Samoa during a 4-month period. On Tonga-Tapu Island in the central Pacific region, 532 men were diagnosed as having filariasis in a single year. A total of 2595 patients with filariasis were admitted to the U.S. Marine Corps hospital at Klamath Falls, Oregon, during a 17-month period.6 Troops were also infected elsewhere in the Pacific region, including Samoa, Wallis Island, New Caledonia, Bougainville, Cook Islands, Woodlark Island (Milne Bay Province, Papua, New Guinea), Ellice Island, Vanuatu, and the Solomon Islands.
According to Swartzwelder,3 filariasis caused a significant loss of manpower and money and seriously compromised the fighting ability of U.S. Army units in the South Pacific. Swartzwelder3 gave the following illustration. The 134th Field Artillery Battalion and the 404th Combat Engineer Company were stationed on Tongatapu Island in the central Pacific region from May 1942 to May 1943 and then on Woodlark Island (Milne Bay Province, Papua, New Guinea) from July 1942 to January 1944. Because of the large number of personnel infected with filariasis, the units were withdrawn to Sydney. Australia, where the prevalence of filariasis (based on clinical findings) among the evacuees was found to be 65% in the 134th Battalion and 55% in the 404th Company. The commanding general of the 6th U.S. Army recommended that the entire unit be withdrawn from active service and return to the United States, because the fighting efficiency of the forces had been seriously impaired and their rehabilitation would extend for an indefinite period. There was also a high economic cost to the U.S. forces, estimated by Napier7 at ~100 million dollars.
Incubation Period
Filariasis is often thought of as a slowly developing disease that requires a long period of exposure for infection. A notable feature of World War II cases was the short exposure time to clinical manifestation of disease, in some cases only 1 month.4 One of the most notable features of these cases was that microfilaremia was detected for only approximately 20 patients.4,5 Despite the failure to demonstrate microfilariae in most cases, there was little doubt about the diagnosis. The clinical findings were typical of acute filariasis and, most telling of all, adult worms were recovered in -30% of cases.4 There are at least two possible explanations for the lack of circulating microfilariae. In expatriate cases, the adult worms induce a marked inflammatory reaction, with a dense collection of inflammatory cells. It is possible that the microfilariae get trapped within the lesion and are unable to make their way into the circulation. Another, probably more plausible, explanation is that the immune response to the parasite among previously unexposed expatriates is more vigorous than that seen among indigenous residents, for whom blunting of the immune response (or "tolerization") starts in the womb,8 and the microfilariae are rapidly destroyed. When the rare cases of microfilaremia did occur, the microfilariae showed the diurnal periodicity pattern that was usually seen in the native population.9 Almost all cases occurring among the U.S. troops the cases could be termed "acute fllariasis" and would fall into the modern category of filarial adenolymphangitis, and it was observed by Huntington et al.I0 that the signs and symptoms were identical to those of the syndrome called "mumu," present in Samoan indigenous populations. The attacks commonly lasted 2 to 5 days, with occasional incidences of 2 weeks or, very rarely, 1 month.11 Recurrent attacks were common, occurring at intervals of a few weeks to several months. Hard exercise, fatigue, and a hot climate were thought to be precipitating factors.4
Presentation of LF
The presenting diagnostic criteria used by Hodge et al.12 are provided in Table I. The most common presenting signs and symptoms in the U.S. Armed Forces cases were pain and swelling of the genitalia, closely followed by lymphangitis of the arms and legs. Lesions of the genitalia (in order of frequency) were funiculitis, epididymitis, scrotal edema and inflammation, lymph scrotum, orchids, hydrocele, and varicocele. Lymphangitis occurred in 51% to 80% of cases. The most common site was the arm, followed by the leg, groin, buttock, and abdomen. An important feature was the tendency for the inflammation to spread in a retrograde direction. Some authors reported skin temperature increases in the affected area but others did not. It should be noted that generalized fever was uncommon. Lymphedema was occasionally observed but was not common. The prevalence of lymphadenitis varied widely from group to group and ranged from 7% to 85%. When lymphadenitis was present, the most commonly affected nodes were the epitrochlear and the inguinal, but other nodes were often involved. Evidence of hypersensitiviry was common, with many patients suffering urticaria and transient swellings. Some of the latter resembled the "Calabar swellings" or "fugitive swelling" usually associated with Loa loa infections. A small number of patients developed a macular erythematous rash. Hypersensitivity-type manifestations were seen only while the patients were a diseaseendemic area, which raises the possibility that they were caused by a reaction to mosquito-injected L3 larvae. One study reported a high incidence of conjunctivitis and some cases of photophobia. The most common laboratory finding was eosinophilia; in a few cases, there was a very high eosinophil count associated with a chronic cough, a hallmark of tropical eosinophilia syndrome.13-15
Psychological disturbances were commonly described.3,6,11,16-22 Typical manifestations were depression, irritability, concentration difficulties, nervousness, anxiety, sleep disorders, and fear. It is possible that filariasis per se does produce some mood swings and depression,17 but many of these symptoms might have been precipitated by the patients observing Polynesian and Melanesian nationals with disfiguring diseases such as severe hydrocele and elephantiasis. Affected men would rather carry their scrotums in a wheelbarrow than risk loss of sexual function with treatment. As it turned out, however, these fears were unfounded. No cases of chronic pathological conditions occurred. Although Behm and Hayman11 reported on 33 patients who believed their sexual potency had been impaired by filariasis and Smith21 reported that many of his patients reported a loss of libido, there was no evidence of long-term effects on sexual function and the prevalence of impotence and sterility was no higher among filariasis patients than in the general population.4 Coggeshall6 reported that 107 of 504 marriages among Marines with a diagnosis of fllariasis resulted in pregnancy within 6 months.
Behm and Hayman11 and Wartman4 reported that in most cases, even without treatment, attacks became progressively milder when patients were removed from the disease-endemic area. Most men were free of symptoms after they had been out of the disease-endemic area for 20 months but occasional cases persisted for up to 3 years. In contrast, Trent,23,24 who reevaluated 25 men who had been diagnosed as having filariasis during World War II, found that many of them still had evidence of the disease 15 years after leaving the disease-endemic area. Intermittent genital symptoms (pain, swelling, and tenderness precipitated or aggravated by standing or physical exercise) were present in 32% of cases. Forty percent of patients had abnormal physical findings, such as thickening of the spermatic cord, the presence of a tender nodule near the testis, induration of the testis, varicocele, or thickening of the scrotal skin. Recurrent lymphangitis still occurred in 12% of cases, with attacks occurring 1 to 3 times per year and lasting for 1 to 3 days. Symptoms consisted of sudden onset of fever, headache, malaise, swelling of affected lymphatic vessels, and swelling of regional lymph nodes. In 68% of cases, there were episodes of swelling of the extremities and enlargement of the regional lymph nodes draining the area. These episodes tended to occur most frequently in the summer months, and the patients complained that the skin of the affected extremities became "puffy, stiff, and tight."
Winstead25 reported on a patient who still complained of symptoms 30 years after contracting the disease during military service in Samoa. At the time of his examination (1972), there was no clinical evidence of active filariasis but the patient had a positive skin test and a weakly positive hemagglutination test. There is no evidence that any of those infected during World War II developed chronic hydrocele or elephantiasis. Although microfilaremia was very rare, occasional cases persisted for up to 15 years.23,24,26
There are several vexing questions to be answered with regard to the U.S. Armed Forces cases. Why did most of the cases occur in the central Pacific area? Most authors seem to believe that it was because the soldiers were in close contact with infected indigenous people in an area in which filariasis was highly endemic. Papua, New Guinea, and the Solomon Islands are also areas in which filariasis is highly endemic, and many U.S. troops were stationed there. Although some U.S. Armed Forces cases did occur in these areas, the numbers seem to be far lower than those for the Pacific area. Wartman4 suggested that the large number of cases in the central Pacific area was attributable to the fact that the vector mosquito is a daytime feeder, the microfilariae have diurnal periodicity, and, because most of the troops' activities took place during the day, the troops were heavily exposed. This does not explain why fewer cases occurred in Papua, New Guinea, and the Solomon Islands. The vectors there are mainly nighttime feeders, but the troops, being in an active theater of war and occupying positions both night and day, would have been heavily exposed. Another interesting observation was the small number of filariasis cases among Australian troops, although they were stationed in highly diseaseendemic areas such as Papua, New Guinea. Walker27 stated that there were only 22 cases of filariasis among Australian troops; some of these men were from Queensland, where filariasis was endemic at the time, and might have acquired the infection before enlisting in the forces. There might simply have been a lack of familiarity with filariasis and thus the diagnosis was missed but this is unlikely, because the Australian forces medical staff members were aware of the risk of filariasis and had been extensively briefed on the U.S. experience in the Pacific region.27
Incidence of LF in More Recent Deployments
Filariasis has also been reported for troops serving in other theaters of war. Alhadeff28 reported cases of acute filariasis among Mauritian troops stationed in the filariasis-endemic areas of Egypt. It difficult to say, however, whether these were locally acquired infections, because filariasis also occurs in Mauritius.29 Filariasis also occurred among expatriate troops serving in Vietnam, where both W. bancrofti and B. malayi occur.29-32 In the 1950s, a syndrome consisting of hypereosinophilia, bronchial asthma, and lymphadenopathy was observed for 151 French and North African troops serving in the Tonkin area of North Vietnam. Microfilariae of B. maiayiwere recovered from the lymph nodes of some patients, but there were no reports of circulating microfilariae. Treatment with arsenical agents or diethylcarbamazine was followed by rapid clinical improvement.33 Brown and Armstrong34 and Sullivan et al.35,36 reported some cases of filariasis among U.S. service personnel. With the use of a soluble-antigen fluorescent antibody test, Colwell et al.31 were able to show that 11% of U.S. service personnel who were stationed in filariasis-endemic regions of South Vietnam had antifilarial antibodies. In contrast, only 3% of those stationed in apparently non-disease-endemic areas were positive. Moreover, when the service personnel were characterized according to the degree of potential exposure, the prevalence of seropositivity among field troops was three times higher than that among base personnel. One serviceman was also found to have circulating microfilariae. Sullivan et al.36 reported a case of clinical filariasis without microfilaremia that rapidly resolved after diethylcarbamazine therapy. Again, there appeared to be reported cases of filariasis among Australian military personnel. Most of Vietnam is malarious and, as far as can be ascertained, U.S. and Australian service personnel were receiving the same antimalarial prophylactic regimen.
Conclusions
LF should always be considered in the differential diagnosis for personnel returning from disease-endemic areas. Filariasis usually expresses itself in a very different manner among exposed military personnel, compared with indigenous populations, which often present images of uncommon complications such as elephantiasis and hydrocele. The clinical presentation of filariasis among military personnel can vary widely and can be very vague and nondescript. All three species cause similar disease.
Acknowledgments
We thank Air Vice Marshal Bruce Short, RFD. Surgeon General of the Australian Defense Force, for his review of this article.
References
1. World Health Organization: Building Partnerships for Lymphatic Filariasis: Strategic Plan. Geneva, Switzerland, World Health Organization, 1999.
2. Ottesen EA: The human filariases: new understandings, new therapeutic strategies. Curr Opin Infect Dis 1994; 7: 550-8.
3. Swartewelder JC: Filariasis bancrofti. In: Preventative Medicine in World War II, Vol 7, pp 63-74. Communicable Diseases: Arthropod-Borne Diseases Other than Malaria. Edited by Coates JB, Hoff EC, Hoff PM. Washington, DC, Medical Department, United States Army, 1963.
4. Wartman WB: Filariasis in American Armed Forces in World War II. Medicine (Baltimore) 1947; 26: 394.
5. Beaver PC: Filariasis without microfilaraemia. Am J Trop Med Hyg 1970; 19: 181-9.
6. Coggeshall LT: Filariasis in the serviceman: retrospect and prospect. JAMA 1946; 131:8-12.
7. Napier LE: Filariasis in U.S. marines [editorial]. J Trop Med Hyg 1947: 50: 189.
8. Ottesen EA: Infection and disease in lymphatic filariasis: an immunologic perspective. Parasitology 1992; 104(Suppl): S71-9.
9. Eyles DE, Hunter GW. Warren VG: The periodicity of microfilariae in two patients with filariasis acquired in the South Pacific. Am J Trop Med 1947; 27: 203-9.
10. Huntington RW, Eichold S, Scott OK: Acute allergic filarial lymphangitis (mumu) in American troops in the Samoanarea in World War II. Am J Trop Med 1950; 30: 873-80.
11. Behm AW, Hayman JM: The course of filariasis after removal from an endemic area. Am J Med Sci 1946; 211: 386-94.
12. Hodge IG, Denhoff E, Van der Veer JB: Early filariasis (Bancrofti) in American soldiers. Am J Med Sci 1945; 210: 207-23.
13. King BG: Early filariasis diagnosis and clinical findings: report of 268 cases in American troops. Am J Trop Med 1944; 24: 285-96.
14. Hirst WR, McCann WJ: Tropical eosinophilia: report of a case. US Navy Med Bull 1945; 44: 1277-81.
15. Pinkston P, Vijayan VK, Nutman TB, et al: Acute tropical eosinophilia: characterization of the lower respiratory tract inflammation and its response to therapy. J Clin Invest 1987; 80: 216-25.
16. Dickson JG, Huntinglon RW, Eichold S: Filariasis in defense force, Samoan Group. US Navy Med Bull 1943; 41: 1240-51.
17. Rome HP, Fogel RH: The psychosomatic manifestations of filariasis. JAMA 1943; 123: 944-7.
18. Englehorn TD, Wellman WE: Filariasis in soldiers on an island in the South Pacific. Am J Med Sci 1945; 209: 141-52.
19. Glauser F: Filariasis in returning marines. US Navy Med Bull 1945; 44: 21-36.
20. Goodman AA, Weinberger EM, Lippincott SW, Marble A, Wright WH: Studies of filariasis in soldiers evacuated from the South Pacific. Ann Intern Med 1945; 23: 823-36.
21. Smith FR: Filariasis: a study of 737 cases so diagnosed. US Navy Med Bull 1945; 44: 719-26.
22. Zeligs MA: Psychosomatic aspects of filariasis. JAMA 1945; 128: 1139-42.
23. Trent SC: Reevaluation of World War II veterans with filariasis acquired in the South Pacific. Am J Trop Med Hyg 1963; 12: 877-87.
24. Trent SC: Treatment of filariasis without microfilaraemia with Hetrazan and triamcinolone. Milit Med 1963; 128: 1104-7.
25. Winstead DK: Filariasis bancrofti and chronic illness behaviour. Milit Med 1978; 143: 869-71.
26. Conn HC, Greenslit FS: Filariasis residuals in veterans with a report of microfilaraemia. Am J Trop Med Hyg 1952; 1: 474-6.
27. Walker AS: Clinical Problems of War. Canberra, Australia, Canberra War Memorial, 1952.
28. Alhadeff R: Clinical aspects of filariasis. J Trop Med Hyg 1955; 58: 173-9.
29. Sasa S: Human filariasis: a global survey of epidemiology and control. Baltimore, MD, University Park Press, 1976.
30. Greenberg JH: Public health problems relating to the Vietnam returnee. JAMA 1969; 207: 697-702.
31. Colwell EJ, Armstrong DR, Brown JD, Duxbury RE, Sadun EH, Legters LJ: Epidemiologic and serologic investigations of filariasis in indigenous populations and American soldiers in South Vietnam. Am J Trop Med Hyg 1970; 19: 227-31.
32. Hembree SC: Distribution and prevalence of Bancroftian filariasis in US Army Special Forces camps in the Republic of Vietnam. Milit Med 1974; 139: 309-12.
33. Galliard H: Outbreak of filariasis (Wuchereria matayi) among French and North African servicemen in North Vietnam. Bull WHO 1957; 16: 601-8.
34. Brown JD, Armstrong DR: Filariasis in indigenous peoples and American service personnel in Vietnam. In: Annual Progress Report of the United States Army Medical Research Team and Institute Pasteur of Vietnam, September 1967 to June 1968, pp 276-90. Washington, DC, Walter Reed Army Institute of Research, 1968.
35. Sullivan TJ, Camahan VA, Cutting RT: Filariasis in American servicemen. In: Annual Progress Report of the United States Army Medical Research Team and Institute Pasteur of Vietnam, July 1968 to June 1969, pp 69-72. Washington, DC, Walter Reed Army Institute of Research, 1969.
36. Sullivan TJ, Carnahan VA, Cutting RT: Filariasis without microfilaraemia: a case report. Milit Med 1970; 135: 797-8.
Guarantor: LTCOL Peter A. Leggat, RAAMC
Contributors: Wayne Melrose, DrPH*; LTCOL Peter A. Leggat, RAAMC[dagger]
* Lymphatic Filariasis Support Center, School of Public Health and Tropical Medicine. James Cook University, Townsville, Australia.
[dagger] Defence Health Services, Army Reserves, Brisbane, Australia, and School of Public Health and Tropical Medicine, James Cook University, Townsville, Australia.
The authors have no financial or other interests to disclose. The views of the authors do not necessarily represent the views of the Australian Defence Force or any other organization referred to in this article.
This manuscript was received for review in February 2004. The revised manuscript was accepted for publication in July 2004.
Reprint & Copyright © by Association of Military Surgeons of U.S., 2005.
Copyright Association of Military Surgeons of the United States Jul 2005
Provided by ProQuest Information and Learning Company. All rights Reserved